UNRESTRICTED GRANT BY
Honorary President: Prof. G. Francini President: Dott. V. Bianco, Dott. R. Petrioli Scientific Coordinator
Dott. Edoardo Francini Faculty
UNIVERSITÀ DEGLI STUDI DI SIENA in collaboration with
GRUPPO DI ONCOLOGIA GERIATRICO ITALIANO (GOGI)
Meeting Venue Hotel NH Via La Lizza, 1, 53100 Siena SI
CME We required 4,9 credits CME for the following professionals: Pathologist, Surgeon, Thoracic Surgeon, Geneticist, Gastroenterologist, Geriatrician, Internal Medicine doctor, Nuclear Medicine doctor, Oncologist, Radiology-Diagnostic and Radiotherapist, Urologist, Pharmacist, Biologist, Nurse
Subscription is free after registration online from the website www.mitcongressi.it section:
3rd RIMOG State of the Art and Novelties in Geriatric Oncology
English is the official language of the Conference. Participants who need the simultaneous translation service are kindly invited to inform the Organizing Secretariat by sending an e-mail to: [email protected] Meeting Secretariat and CME Provider
MI&T Srl - Viale Carducci, 50 - 40125 Bologna
Tel. 051 220427 - [email protected] - www.mitcongressi.it Massimo Aglietta Turin, I
Gianni Amunni Florence, I Joaquim Bellmunt Boston, USA Pierluigi Benedetti Panici Rome, I Alfredo Berruti Brescia Vincenzo Bianco Rome, I Stefania Brozzetti Rome, I Federico Cappuzzo Ravenna, I Paolo Giovanni Casali Milan, I Stefano Cascinu Modena, I Angelo Di Leo Prato, I Karim Fizazi Paris, F Guido Francini Siena, I Valtere Giovannini Siena, I Celestia S. Higano Seattle, USA Joleen M. Hubbard Rochester, USA
Sibylle Loibl Francoforte, D Salvatora Tindara Miano Siena, I Andrea Necchi Milan, I
Edith A. Perez San Francisco, USA Iacopo Petrini Pisa, I
Roberto Petrioli Siena, I Camillo Porta Pavia, I Giuseppe Procopio Milan, I Mario Roselli Rome, I Antonio Russo Palermo, I Mario Santarelli Rieti, I Manuela Schmidinger Vienna, A Christopher J. Sweeney Boston, USA May-Ellen Taplin Boston, USA Giuseppe Tonini Rome, I
3
rdRIMOG
State of the Art and Novelties in Geriatric Oncology
Siena, September 20
th2019
Hotel NH
Honorary President: Prof. G. Francini President: Dott.V. Bianco, Dott. R. Petrioli
CON IL PATROCINIO DI:
September 20
th2019
08:30 Registration
09:00 Opening - G. Francini
09:15 Welcome - V. Giovannini and G. Amunni
SESSION I MANAGEMENT OF THE ELDERLY WITH CANCER
Co-chairs: G. Amunni, V. Bianco
09:30 Treatment of bone metastases in older cancer patients - A. Berruti
09:45 The prevention and management of CINV in the elderly with cancer - V. Bianco 10:00 Management of pain in geriatric oncology - M. Santarelli
10:15 Surgery of liver metastasis in older patients - S. Brozzetti 10:30 Coffee break
SESSION II LUNG CANCER
Co-chairs: A. Russo, F. Cappuzzo
11:00 NSCLC: Liquid biopsy in daily clinical practice - A. Russo 11:15 NSCLC: Treatment of oncogene addicted disease - I. Petrini 11:30 Role of immunotherapy in the elderly with NSCLC - F. Cappuzzo 11:45 Panel discussion
SESSION III COLORECTAL CANCER
Co-chairs: J.M. Hubbard, G. Tonini
12:00 Adjuvant therapy in the elderly patient with CRC -S. Cascinu 12:15 Treatment of old patients with metastatic CRC -M. Roselli
12:30 Immunotherapy for the elderly CRC patient: state of existing evidence -J.M. Hubbard 12:45 Panel discussion
13:00 Lunch
SESSION IV BREAST CANCER
Co-chairs: E.A. Perez, A. Di Leo
14:00 Treatment of the elderly with hormonoresponsive metastatic breast cancer - A. Di Leo 14:15 Triple negative breast cancer in the elderly: state of existing evidence -S. Loibl 14:30 New treatments for HER2-, ER+ disease in the elderly -E.A. Perez
14:45 Panel discussion
SESSION V PROSTATE CANCER
Co-chairs: K. Fizazi, C.S. Higano
15:00 Neoadjuvant therapy: ready for prime time? - M.E. Taplin
15:15 The management of non-metastatic castration-resistant prostate cancer - K. Fizazi 15:30 Treatment of metastatic hormone sensitive prostate cancer
what is the status? - C.J. Sweeney 15:45 Panel discussion
SESSION VI KIDNEY CANCER
Co-chairs: C. Porta, M. Schmidinger
16:00 Evolving treatment algorithm for mRCC - M. Schmidinger 16:15 Immunotherapy for mRCC: new perspectives - G. Procopio 16:30 Panel discussion
SESSION VII UROTHELIAL CANCER
Co-chairs: J. Bellmunt, A. Necchi
16:45 Immunotherapy for urothelial carcinoma - A. Necchi
17:00 Metastatic urothelial cancer: state of the art and new challenges - J. Bellmunt 17:15 Panel discussion
SESSION VIII RARE TUMORS
Co-chairs: M. Aglietta, P. Casali
17:30 Medical treatment of elderly patients with soft tissue sarcoma - P. Casali 17:45Desmoid tumors: new therapies at the horizon? - S.T. Miano
18:00Treatment of the elderly with ovarian cancer - P. L. Benedetti Panici 18:15 Closing
